Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Neurological, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
World Neurosurg. 2019 Oct;130:e753-e759. doi: 10.1016/j.wneu.2019.06.214. Epub 2019 Jul 5.
Aneurysmal subarachnoid hemorrhage (aSAH) requires complex multidisciplinary care. After initial treatment (index hospital), readmission to a different hospital (nonindex) can compromise quality of care, resulting in increased morbidity. We aimed to evaluate factors associated with nonindex readmission and evaluate association of nonindex hospital readmission on outcomes in patients with ruptured aneurysm.
Readmissions within 90 days after aSAH treatment were identified in the 2010-2014 Nationwide Readmissions Database. Multivariable logistic regression identified patient and hospital characteristics associated with nonindex readmission. Separate multivariable models determined increased morbidity or risk of second readmission for nonindex readmissions.
A total of 9254 patients who underwent treatment of ruptured aneurysms from 2010 to 2014 were identified. Of these, 1985 (21.5%) were readmitted within 90 days. Three hundred and fifty-five of these readmissions (17.9%) occurred to nonindex hospitals. Patients that were discharged to a skilled nursing or other facility (odds ratio [OR], 1.70; 95% confidence interval [CI], 1.27-2.28]) had higher odds of nonindex readmission, whereas patients with private insurance were associated with lower odds of nonindex readmission (OR, 0.65; 95% CI, 0.46-0.92). Patients readmitted to a nonindex (vs. index) hospital were associated with increased likelihood of major complications (OR, 1.71; 95% CI, 1.18-2.48) and second readmissions (OR, 1.51; 95% CI, 1.17-1.96).
After treatment of a ruptured cerebral aneurysm, 17.9% of readmissions occurred at a nonindex hospital. These patients were at increased risk for major complications or subsequent readmissions, which may be because of care fragmentation. Interventions aimed at improving continuity of care may reduce higher morbidity associated with nonindex readmission.
动脉瘤性蛛网膜下腔出血(aSAH)需要复杂的多学科护理。在初始治疗(索引医院)后,转至不同医院(非索引医院)可能会影响护理质量,导致发病率增加。我们旨在评估与非索引再入院相关的因素,并评估破裂性动脉瘤患者非索引医院再入院对结局的影响。
在 2010 年至 2014 年的全国再入院数据库中,确定 aSAH 治疗后 90 天内的再入院情况。多变量逻辑回归确定与非索引再入院相关的患者和医院特征。单独的多变量模型确定非索引再入院的发病率增加或再次再入院的风险。
共确定了 2010 年至 2014 年间接受破裂性动脉瘤治疗的 9254 例患者。其中,90 天内有 1985 例(21.5%)再入院。其中 355 例(17.9%)再入院至非索引医院。出院至康复护理院或其他机构的患者(比值比 [OR],1.70;95%置信区间 [CI],1.27-2.28)更有可能发生非索引再入院,而有私人保险的患者发生非索引再入院的可能性较低(OR,0.65;95%CI,0.46-0.92)。与索引医院相比,非索引(vs. 索引)医院再入院的患者更有可能发生主要并发症(OR,1.71;95%CI,1.18-2.48)和再次再入院(OR,1.51;95%CI,1.17-1.96)。
破裂性脑动脉瘤治疗后,17.9%的再入院发生在非索引医院。这些患者发生主要并发症或再次再入院的风险增加,这可能是因为护理不连续。旨在改善护理连续性的干预措施可能会降低与非索引再入院相关的更高发病率。